Related Experiment Video

Updated: Feb 9, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

16.0K

Myotonic dystrophy type 1: clinical manifestations in children and adolescents

Genevieve Ho1, Kate A Carey1, Michael Cardamone1,2

  • 1Discipline of Paediatrics, School of Women's and Children's Health, UNSW Medicine, UNSW Sydney, Sydney, New South Wales, Australia.

Archives of Disease in Childhood
|June 7, 2018
PubMed

Insights

Myotonic dystrophy type 1 (DM1) in children presents unique challenges, differing from adult forms. This study proposes a pediatric-focused management framework addressing diverse health issues in childhood DM1 patients.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Myotonic dystrophy type 1 (DM1) is a severe autosomal dominant neuromuscular disorder.
  • Current management guidelines for DM1 are primarily adult-focused, leaving a gap in pediatric care.
  • Understanding DM1's pediatric clinical spectrum is crucial for developing targeted interventions.

Purpose of the Study:

  • To profile the clinical characteristics of DM1 in childhood.
  • To propose a framework for guiding pediatric-focused management of DM1.
  • To highlight the differences in disease presentation between congenital (CDM1) and juvenile (JDM1) forms.

Main Methods:

  • Retrospective study of 40 children diagnosed with DM1.
  • Data collected over 513 follow-up years at Sydney Children's Hospital.
  • Analysis of 143 clinical parameters to characterize disease spectrum.

Main Results:

  • The clinical spectrum of DM1 in childhood differs significantly from adults.
  • Congenital myotonic dystrophy (CDM1) exhibits more severe health issues than juvenile DM1 (JDM1).
  • High prevalence of intellectual, fine motor, gastrointestinal, and neuromuscular deficits observed in both CDM1 and JDM1 patients.

Conclusions:

  • DM1 in childhood presents diverse health consequences requiring specialized pediatric care.
  • A multidisciplinary management approach is essential for addressing cognition, musculoskeletal, gastrointestinal, respiratory, cardiac, and sleep issues.
  • The study provides a framework to guide the development of comprehensive pediatric DM1 management strategies.
Abstract

Keywords:
childhood myotonic dystrophyclinical managementclinical manifestationsneuromuscularquality of life

More Related Videos

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.9K
A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy05:54

A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy

Published on: December 29, 2017

10.5K

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
881
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
261
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
548
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
371
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
674
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
612